Skip Nav Destination
Issues
Minireview
Perspectives
Featured Articles
Clinical Trials
Risk and Prognosis of Central Nervous System Leukemia in Patients with Philadelphia Chromosome-Positive Acute Leukemias Treated with Imatinib Mesylate
Heike Pfeifer; Barbara Wassmann; Wolf-Karsten Hofmann; Martina Komor; Urban Scheuring; Patrick Brück; Anja Binckebanck; Eberhard Schleyer; Nicola Gökbuget; Thomas Wolff; Michael Lübbert; Lothar Leimer; Harald Gschaidmeier; Dieter Hoelzer; Oliver G. Ottmann
Pharmacokinetic Study of Cisplatin and Infusional Etoposide Phosphate in Advanced Breast Cancer with Correlation of Response to Topoisomerase IIα Expression
Jeremy P. Braybrooke; Nicola C. Levitt; Simon Joel; Theresa Davis; Srinivasan Madhusudan; Helen Turley; Sue Wilner; Adrian L. Harris; Denis C. Talbot
Molecular Oncology, Markers, Clinical Correlates
A Training-Testing Approach to the Molecular Classification of Resected Non-Small Cell Lung Cancer
Noboru Yamagata; Yu Shyr; Kiyoshi Yanagisawa; Mary Edgerton; Thao P. Dang; Adriana Gonzalez; Sorena Nadaf; Paul Larsen; John R. Roberts; Jonathan C. Nesbitt; Roy Jensen; Shawn Levy; Jason H. Moore; John D. Minna; David P. Carbone
Relationships between Plasma Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 and Second Breast Cancer Risk in a Prevention Trial of Fenretinide
Andrea Decensi; Umberto Veronesi; Rosalba Miceli; Harriet Johansson; Luigi Mariani; Tiziana Camerini; Maria Gaetana Di Mauro; Elena Cavadini; Giuseppe De Palo; Alberto Costa; Marjorie Perloff; Winfred F. Malone; Franca Formelli
Experimental Therapeutics, Preclinical Pharmacology
ZD1839 (Iressa) Modifies the Activity of Key Enzymes Linked to Fluoropyrimidine Activity: Rational Basis for a New Combination Therapy with Capecitabine
Nicolas Magné; Jean-Louis Fischel; Alain Dubreuil; Patricia Formento; Joseph Ciccolini; Jean-Louis Formento; Céline Tiffon; Nicole Renée; Sandrine Marchetti; Marie-Christine Etienne; Gérard Milano
Regular Articles
Clinical Trials
A Phase I, Pharmacokinetic, and Biological Study of the Farnesyltransferase Inhibitor Tipifarnib in Combination with Gemcitabine in Patients with Advanced Malignancies
Amita Patnaik; S. Gail Eckhardt; Elzbieta Izbicka; Anthony A. Tolcher; Lisa A. Hammond; Chris H. Takimoto; Garry Schwartz; Heather McCreery; Andrew Goetz; Masataka Mori; Kazutoyo Terada; Lou Gentner; Mary-Ellen Rybak; Henry Richards; Steven Zhang; Eric K. Rowinsky
SU5416 Plus Interferon α in Advanced Renal Cell Carcinoma: A Phase II California Cancer Consortium Study with Biological and Imaging Correlates of Angiogenesis Inhibition
Primo N. Lara, Jr.; David I. Quinn; Kim Margolin; Frederick J. Meyers; Jeff Longmate; Paul Frankel; Philip C. Mack; Corinne Turrell; Peter Valk; Jyotsna Rao; Penelope Buckley; Ted Wun; Robert Gosselin; Irina Galvin; Paul H. Gumerlock; Heinz Josef Lenz; James H. Doroshow; David R. Gandara
Cancer Biology, Immunology, Cytokines
Research Articles
Molecular Oncology, Markers, Clinical Correlates
Retention of the p53 Codon 72 Arginine Allele Is Associated with a Reduction of Disease-Free and Overall Survival in Arginine/Proline Heterozygous Breast Cancer Patients
Massimiliano Bonafé; Claudio Ceccarelli; Fulvia Farabegoli; Donatella Santini; Mario Taffurelli; Cristiana Barbi; Erika Marzi; Chiara Trapassi; Gianluca Storci; Fabiola Olivieri; Claudio Franceschi
Molecular Detection of Breast Cancer Cells in the Peripheral Blood of Advanced-Stage Breast Cancer Patients Using Multimarker Real-Time Reverse Transcription-Polymerase Chain Reaction and a Novel Porous Barrier Density Gradient Centrifugation Technology
Megan K. Baker; Kaidi Mikhitarian; Walid Osta; Kathi Callahan; Rana Hoda; Frank Brescia; Rayna Kneuper-Hall; Michael Mitas; David J. Cole; William E. Gillanders
Interleukin 1 System and Sex Steroid Receptor Expression in Human Breast Cancer: Interleukin 1α Protein Secretion Is Correlated with Malignant Phenotype
Christian F. Singer; Nicole Kronsteiner; Gernot Hudelist; Erika Marton; Ingrid Walter; Marion Kubista; Klaus Czerwenka; Martin Schreiber; Michael Seifert; Ernst Kubista
Evaluation of Urinary Plasminogen Activator, Its Receptor, Matrix Metalloproteinase-9, and von Willebrand Factor in Pancreatic Cancer
Shashi R. Harvey; Thelma C. Hurd; Gabor Markus; Maisie I. Martinick; Remedios M. Penetrante; Dongfeng Tan; Preeti Venkataraman; Nisha DeSouza; Sheila N. J. Sait; Deborah L. Driscoll; John F. Gibbs
Experimental Therapeutics, Preclinical Pharmacology
Multidrug-Resistant Tumor Cells Remain Sensitive to a Recombinant Interleukin-4-Pseudomonas Exotoxin, Except When Overexpressing the Multidrug Resistance Protein MRP1
Mariska C. de Jong; George L. Scheffer; Henk J. Broxterman; Jan H. Hooijberg; Jerry W. Slootstra; Rob H. Meloen; Robert J. Kreitman; Syed R. Husain; Bharat H. Joshi; Raj K. Puri; Rik J. Scheper
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds